As a result, a negative trend has emerged for the eastern regions: the total share of the Siberian and Far Eastern federal districts in the total Russian production of medicines and medical materials gradually decreased from 8.4% in 2017 to 7.4% in 2020.
← all excerpts
Location of the Largest Pharmaceutical Companies in Russia: Contribution to Regional Divergence or Convergence?
2
—
—
The sentences
The fact is that in recent years there has been an obvious trend towards a reduction in the share of production of pharmaceutical substances in total production in the industry: from 25.4% in 2017 to 9.1% in 2020.